Resources
Vein Graft Disease: What Have We Learned about Making a Vein into an Artery?
In this presentation, Dr. Michael S. Conte, M.D. discusses his work in studying and treating vein graft disease. He explains the etiology, histology, and risk factors of vein graft failure, including the dominant impact of vein quality of grafting procedure success rates. He cites several studies that provide evidence on methods of identifying, preventing, and treating this disease.
CME Information
CME Credit Available
You may claim CME credit after watching this activity.
Needs Statement
General, plastic, thoracic, vascular, cardiothoracic, abdominal transplantation and surgical oncology physicians, residents, fellows, and medical students need to be regularly updated on novel therapies, as well as advances in surgical care and clinical practices that will aid them in treating a variety of surgical procedures to increase the patient care experience and improve practice efficiency.
Objectives
At the conclusion of this activity, the participant should be able to:
- Summarize the process of adaptive venous arterialization.
- Review the risk factors and potential mechanisms of vein graft disease/failure.
- Review the evidence on prevention and treatment of vein graft disease.
Target Audience
- Physicians
- Medical Students
- Fellows
- Residents
Accreditation/Credit Designation
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Program Director
-
James W. Suliburk, M.D., FACS
Associate Professor and Chief, Endocrine Surgery
Baylor College of Medicine
Term of Approval
January 1, 2020 through January 31, 2022. Original release date: January 1, 2020.
Disclosure Policy
The Office of Continuing Medical Education (OCME) makes every effort to develop CME activities that are scientifically based, accurate, current, and objectively presented. In accordance with the Accreditation Council for Continuing Medical Education Standards for Commercial SupportSM, Baylor College of Medicine (BCM) has implemented a mechanism requiring everyone in a position to control the content of an educational activity (e.g., directors, planning committee members, contributors, peer reviewers) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships: 1) at the time of the activity or within 12 months prior; and 2) of their spouses/partners.
Baylor College of Medicine does not view the existence of interests or relationships with commercial entities as implying bias or decreasing the value of a presentation. It is up to the participants to determine whether the interests or relationships influence the presenter with regard to exposition or conclusions.
If at any time during this activity you feel that there has been commercial or promotional bias, please inform us by using the commercial bias comments box in the evaluation form. Please answer the questions about balance in the CME activity evaluation candidly.
Disclosures
The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:
Presenter
-
Michael S. Conte, M.D.
Professor and Chief
University of California San Francisco School of Medicine
Disclosure:
- Research Support: Metagenics, Inc.
- Consultancy: Abbott Vascular; AnGes, Inc.
Program Director
-
James W. Suliburk, M.D., FACS
Associate Professor and Chief, Endocrine Surgery
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Planning Committee Members
-
John A Goss, M.D.
Professor of Surgery and Chief, Division of Abdominal Transplantation
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Scott A. LeMaire, MD, FACS, FAHA, FCCP
Professor and Vice-Chair for Research
Baylor College of Medicine
Disclosure:
- Research Support: Terumo Aortic; WL Gore and Associates; CytoSorbants
- Intellectual Property: Blackwell Publishing; Wiley Publishing
- Advisory Committee Membership: Acer Therapeutics
- Consultancy: Terumo Aortic
-
Todd Rosengart, M.D., F.A.C.S.
DeBakey-Bard Chair of Surgery
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
James W. Suliburk, M.D., FACS
Associate Professor and Chief, Endocrine Surgery
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Contributor
-
Michael S. Conte, M.D.
Professor and Chief
University of California San Francisco School of Medicine
Disclosure:
- Research Support: Metagenics, inc.
- Consultancy: Abbott Vascular; AnGes, Inc.
CME Credit Available
You may claim CME credit after watching this activity.
Presenter:
-
Michael S. Conte, M.D.
Professor and Chief University of California San Francisco School of Medicine